Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability
Agomelatine is a new antidepressant having very low oral drug bioavailability less than 5% due to being liable to extensive hepatic 1st pass effect. This study aimed to deliver agomelatine by transdermal route through formulation and optimization of microemulsion gel. Pyramidal screening was perform...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis Group
2017-01-01
|
| Edice: | Drug Delivery |
| Témata: | |
| On-line přístup: | http://dx.doi.org/10.1080/10717544.2017.1365392 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|